An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates.

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis.

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.

The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV).

Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro.

A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection.

A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis.

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.

Head-to-head comparison of the diagnostic accuracies of BD Veritor™ System RSV and Quidel® Sofia® RSV FIA systems for respiratory syncytial virus (RSV) diagnosis.

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.

An overview of respiratory syncytial virus.

Respiratory syncytial virus infection: an innate perspective.

Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13.

CT-morphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults.

Declining child mortality rates in Nicaragua.

Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection.

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.

Respiratory syncytial virus infections.

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.

Humanised monoclonal antibody to respiratory syncytial virus.

Suggest Documents

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis.

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.

The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV).

Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro.

A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection.

A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis.

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.

Head-to-head comparison of the diagnostic accuracies of BD Veritor™ System RSV and Quidel® Sofia® RSV FIA systems for respiratory syncytial virus (RSV) diagnosis.

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.

An overview of respiratory syncytial virus.

Respiratory syncytial virus infection: an innate perspective.

Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13.

CT-morphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults.

Declining child mortality rates in Nicaragua.

Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection.

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.

Respiratory syncytial virus infections.

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.

Humanised monoclonal antibody to respiratory syncytial virus.

An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates.

Recommend Documents

Follow Us